Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20171030037093N32Phase 3Completed
Phase 3, randomised, double-blind trial of beclomethasone in nasal polyp (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Sino-Nasal Outcome Test-22 score and Lund-Mackay score. Started Feb 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20171030037093N32.